BioIQ, an Atlanta, GA-based healthcare technology company, raised $26.5M in financing.
The round was led by HealthQuest Capital, with participation from Arboretum Ventures and select insiders. In conjunction with the funding, Todd Creech, Partner at HealthQuest Capital, and Paul McCreadie, Managing Director at Arboretum Ventures, joined BioIQ’s board of directors.
The company will use the funds to to expand its reach into new markets and accelerate product growth and innovation.
Led by Justin Bellante, CEO, BioIQ aims to simplify health testing for health plans, employers and enterprises of all sizes and empower people to take action to improve their health. The BioIQ Platform provides tools for orchestrating health testing programs and biometric screening events across multiple vendors, as well as multi-channel communication tools for engaging and motivating participants at every step of the way. It also provides a means to intervene when risks for chronic conditions are found — with a unified solution for keeping at-risk populations up-to-date with health testing, along with data analysis for managing risks and resources for people.